Mounjaro KwikPen in South Africa: strengths, use and storage

What is the Mounjaro KwikPen?

The Mounjaro KwikPen is a pre-filled, single-patient injection pen holding four fixed weekly doses of tirzepatide at one strength. You attach a fresh pen needle, prime the pen, dial one dose and inject under the skin once a week. After the fourth dose, or 30 days after first use, the pen is discarded.

Eli Lilly makes the pen and Aspen Pharmacare distributes it in South Africa. SAHPRA has registered tirzepatide for type 2 diabetes and, since October 2025, for chronic weight management in adults, so the same pen serves both registered uses.

Because tirzepatide is a Schedule 4 medicine, a doctor must assess you and authorise treatment before a pharmacy can dispense a pen, and the strength you receive always matches your doctor-confirmed treatment plan.

Which Mounjaro KwikPen strengths are available in South Africa?

Six KwikPen strengths are registered in South Africa: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Each strength is its own pen, each pen holds four weekly doses, and every dose is dialled and injected the same way regardless of strength.

One pen covers one four-week step at the fastest registered pace, so moving up the schedule means collecting a different pen, not adjusting the one you have. Every injection delivers the same 0.6 ml of liquid; the concentration inside the cartridge is what changes between strengths.

Your doctor sets the pace of any increase, and many people hold a middle strength for months. The full schedule, including why treatment starts low, is in our Mounjaro dosage guide.

When did the KwikPen arrive in South Africa?

Mounjaro launched in South Africa in December 2024 in single-dose vials, registered at that point for type 2 diabetes, while SAHPRA still evaluated the pen presentation. The KwikPen followed in late 2025, announced alongside the October 2025 weight-management registration, and pharmacy supply has since shifted to it, so the pen is what Dischem, Clicks and independent pharmacies now stock.

The vial-first launch came down to regulatory timing. Aspen's December 2024 announcement noted that the KwikPen presentation was still under evaluation at SAHPRA, so the vial reached pharmacies first.

Stock still fluctuates. Individual strengths sell out at branch level, so phone your branch before collection day, and if your strength is out everywhere nearby, ask your doctor before accepting a different strength or format.

Check four things when you collect a pen: it comes cold from the pharmacy fridge, sealed in Eli Lilly packaging, with a batch number and expiry date, in the strength on your treatment plan. A pen offered outside a licensed pharmacy is not the registered product, whatever the packaging claims; SAHPRA has warned about falsified products in this class, and suspicious sellers can be reported to its 24-hour hotline on 0800 204 307.

How does the Mounjaro KwikPen work?

The KwikPen delivers one fixed dose at a time. You screw on a new needle, prime the pen until a drop of medicine appears at the tip, turn the dose knob until the 1 shows in the window, insert the needle and hold the knob down for a slow count of five.

The dose window is the pen's feedback system. It shows the extended line while you prime, the 1 when a full dose is dialled, and 0 once the dose has gone in. If the window has not returned to 0 after your injection, put the needle back into your skin and finish the push; do not redial.

You will hear clicks as the knob turns. The clicks are a mechanical feature, not a measuring tool, and there is no way to dial a partial or half dose on this pen.

Your first injection should follow a demonstration by the doctor or pharmacist managing your treatment, not a written guide alone. The complete weekly routine, from hand washing to site rotation, is in how to inject Mounjaro.

Which needles fit the Mounjaro KwikPen?

Screw-on pen needles marked as KwikPen compatible, sold separately at pharmacies; the pen box does not include them. The instructions tell you to ask your pharmacist if you are unsure which needle to use, and short needles are the norm for injecting under the skin. Pick up a full month's supply when you collect the pen, because every injection needs a fresh one.

Reused needles blunt quickly, hurt more and can block, and a blocked needle is a common reason a pen fails to prime. A small sharps container, also sold at pharmacies, completes the kit; disposal is covered further down.

Never store the pen with a needle attached. An attached needle can leak, let air into the cartridge and affect dose accuracy. Needle off, cap on, back into storage, every week.

How do you store the Mounjaro KwikPen?

Unused Mounjaro KwikPens stay in the fridge at 2 to 8 degrees Celsius and must never freeze. Once you take the first dose, the pen may live out of the fridge below 30 degrees Celsius and must be used or discarded within 30 days, which matches its four weekly doses.

Check the liquid before every injection: colourless to slightly yellow, with no cloudiness or particles. Lilly also confirms that an in-use pen put back into the fridge within the 30-day window can still be used.

Load shedding rarely threatens the pen. A closed fridge holds a safe temperature for a few hours, and an in-use pen is covered by the 30-day allowance anyway. For longer outages, move unopened pens to a cooler box with ice packs, wrapped in a cloth so the pen never touches the packs and cannot freeze.

Can you travel with the KwikPen?

Yes. A Mounjaro KwikPen flies in hand luggage, never in checked baggage, because the cargo hold can drop below freezing and a frozen pen must be discarded. Keep the pen in its original box with the pharmacy label, and carry a short letter from your doctor for international trips.

The 30-day clock keeps running while you travel, so note the date of your first dose from the pen before you leave. An in-use pen handles a trip below 30 degrees Celsius without refrigeration; an unopened spare goes back into a fridge at your destination.

Heat is the bigger risk on the ground. A parked car passes 30 degrees Celsius within minutes, so the pen never waits in the cubbyhole or boot, and a small cooler pouch with a gel pack covers long road trips.

How do you dispose of the pen and needles?

Used needles go straight into a sharps container after each injection, never loose into household rubbish. Used pens are handed back or discarded as your pharmacist advises, never binned with a needle still attached. Pharmacies sell small sharps containers, and many accept full ones back for medical-waste disposal.

Loose needles put cleaners, waste collectors and children at risk of needlestick injuries. If you cannot get a purpose-made container immediately, a rigid plastic bottle with a secure lid, clearly marked and kept away from children, is an accepted stopgap; swap to a proper container as soon as you can.

Phone ahead to confirm your branch takes full containers back. Some clinics and GP practices accept them too.

How does the KwikPen differ from the vial and the single-dose pen?

The KwikPen is a multi-dose pen holding four weekly doses. The Mounjaro vial is a single glass container you draw up with a syringe and use once. The single-dose pen sold in the United States injects one dose automatically through a built-in needle. South African pharmacies stock the KwikPen.

The distinction matters because many instruction videos come from the US and show the auto-injector, which has no needle to attach, no priming step and no dose to dial. Following those steps with a KwikPen will go wrong, so use the KwikPen instructions in the box and the demonstration you were given.

Whatever the container, the medicine is the same tirzepatide at the same weekly doses. The full format comparison, including the launch vials still moving through the supply chain, is in Mounjaro vial vs pen.

What does the Mounjaro KwikPen cost in South Africa?

The Medicine Price Registry, which mirrors the Department of Health's Single Exit Price database and was updated in May 2026, lists the Mounjaro KwikPen at R4,041 for the 2.5 mg pen, R4,105 for 5 mg, R6,398 for 7.5 mg and 10 mg, and R8,865 for 12.5 mg and 15 mg, before a regulated dispensing fee of roughly R435 to R700 per pen. One pen holds four weekly doses, so each figure covers roughly a month. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

The number is regulated. Every pharmacy starts from the same national Single Exit Price and may add only the capped dispensing fee on top, so shopping around moves the total very little. Divide the pen price by four and the lowest strength lands just over R1,000 a week before the dispensing fee.

Budget for the strength you expect to hold rather than the starting pen, because the cost climbs with the dose schedule. The full breakdown, including the annual price adjustment cycle and what sits around the medicine itself, is in how much Mounjaro costs in South Africa.

Which KwikPen mistakes should you avoid?

Most Mounjaro KwikPen problems trace back to a handful of habits. Each one is avoidable with a small change to the weekly routine.

• Storing the pen with a needle attached: it can leak and pull air into the cartridge.
• Using a pen that froze: freezing damages the medicine invisibly, and the pen must be discarded even after it thaws.
• Reusing needles: blunt needles hurt more, block more often and raise infection risk.
• Sharing a pen: it is a single-patient device, and sharing can transmit infection even with a fresh needle.
• Stretching or splitting doses: the pen delivers fixed doses by design, and any dose change belongs to your doctor.
• Leaving the pen in a car: cabin temperatures pass 30 degrees Celsius within minutes.
• Injecting past the limits: after the fourth dose or 30 days from first use, the pen is finished, even if liquid remains.

If a pen ever looks damaged, or the liquid is cloudy or carries particles, do not inject from it. Ask your pharmacist to check it first.

What side effects come with the medicine in the pen?

The pen changes how you handle the medicine; the side effects belong to tirzepatide itself. Its common side effects are digestive: nausea, diarrhoea, constipation and vomiting, mostly around dose increases, usually settling as the body adjusts. Injection-site redness or itching affects a minority of users, and rotating sites each week helps.

Mounjaro is not suitable in pregnancy or while breastfeeding, or for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome, and a history of pancreatitis needs a careful medical decision. Severe, persistent stomach pain can signal pancreatitis: seek medical care immediately.

The frequency, duration and management of each effect, including the rare serious risks worth knowing by name, are covered in Mounjaro side effects.

Who decides whether the KwikPen suits you?

A doctor. Tirzepatide is a Schedule 4 medicine, so treatment starts with a doctor's assessment of your health, weight history, current medicines and contraindications, and continues with follow-up reviews as the dose changes. Pharmacies dispense the strength on your treatment plan; they cannot move you up or down the schedule.

The device belongs in that conversation too. The official instructions state that people with impaired vision should not use the KwikPen without help from someone trained on it, and stiff or painful hands are worth raising before your first demonstration so the technique can be adapted.

Structured follow-up is where dose decisions, side-effect management and technique checks happen; what to expect from doctor-led treatment describes how that works in practice. Whether this pen, another format or no medicine at all is the right route is decided by a doctor on assessment.

Frequently asked questions